BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6429674)

  • 1. Six-hydroxydopamine induced hyperactivity: neither sex differences nor caffeine stimulation are found.
    Erinoff L; Kelly PH; Basura M; Snodgrass SR
    Pharmacol Biochem Behav; 1984 May; 20(5):707-13. PubMed ID: 6429674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
    Erinoff L; Snodgrass SR
    Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-dependent effects of 6-hydroxydopamine on locomotor activity in the rat.
    Erinoff L; MacPhail RC; Heller A; Seiden LS
    Brain Res; 1979 Mar; 164():195-205. PubMed ID: 427556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraventricular 6-hydroxydopamine in the newborn rat and locomotor responses to drugs in infancy: no support for the dopamine depletion model of minimal brain dysfunction.
    Pappas BA; Gallivan JV; Dugas T; Saari M; Ings R
    Psychopharmacology (Berl); 1980; 70(1):41-6. PubMed ID: 6775333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Magnitude and duration of hyperactivity following neonatal 6-hydroxydopamine is related to the extent of brain dopamine depletion.
    Miller FE; Heffner TG; Kotake C; Seiden LS
    Brain Res; 1981 Dec; 229(1):123-32. PubMed ID: 6796194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of d-amphetamine and apomorphine upon operant behavior and schedule-induced licking in rats with 6-hydroxydopamine-induced lesions of the nucleus accumbens.
    Robbins TW; Roberts DC; Koob GF
    J Pharmacol Exp Ther; 1983 Mar; 224(3):662-73. PubMed ID: 6402587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible involvement of serotonergic neurons in the reduction of locomotor hyperactivity caused by amphetamine in neonatal rats depleted of brain dopamine.
    Heffner TG; Seiden LS
    Brain Res; 1982 Jul; 244(1):81-90. PubMed ID: 6288184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine.
    Breese GR; Baumeister AA; McCown TJ; Emerick SG; Frye GD; Crotty K; Mueller RA
    J Pharmacol Exp Ther; 1984 Nov; 231(2):343-54. PubMed ID: 6149306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired acquisition of an operant response in young rats depleted of brain dopamine in neonatal life.
    Heffner TG; Seiden LS
    Psychopharmacology (Berl); 1983; 79(2-3):115-9. PubMed ID: 6405418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of a dimethylsulfonium analog of dopamine after injection into the nucleus accumbens and the striatum.
    Boldry R; Chang Y; Miller DD; Uretsky NJ
    Pharmacol Biochem Behav; 1986 Feb; 24(2):223-8. PubMed ID: 3081914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Norepinephrine stimulates behavioral activation in rats following depletion of nucleus accumbens dopamine.
    Swerdlow NR; Koob GF
    Pharmacol Biochem Behav; 1989 Jul; 33(3):595-9. PubMed ID: 2511575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperactivity in neonatally dopamine-lesioned rats requires residual activity in mesolimbic dopamine neurons.
    Luthman J; Lindqvist E; Ogren SO
    Pharmacol Biochem Behav; 1995 May; 51(1):159-63. PubMed ID: 7617728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential effects of alpha-methyl-p-tyrosine and 6-hydroxydopamine on pentylenetetrazol seizures in mice.
    Abed WT
    Pharmacol Biochem Behav; 1986 Nov; 25(5):949-52. PubMed ID: 3097680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of manipulating central catecholamines on puberty and the surge of luteinizing hormone and gonadotropin releasing hormone induced by pregnant mare serum gonadotropin in female rats.
    Sarkar DK; Smith GC; Fink G
    Brain Res; 1981 Jun; 213(2):335-49. PubMed ID: 6113874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Catecholamine-serotonin interaction effects on activity in rats neonatally treated with 6-hydroxydopamine.
    Olds ME; Fobes JL; Albert V
    Psychopharmacology (Berl); 1981; 73(1):31-3. PubMed ID: 6785786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hyperactivity in developing rats: sex differences in 6-hydroxydopamine and amphetamine effects.
    Concannon JT; Schechter MD
    Pharmacol Biochem Behav; 1981 Jan; 14(1):5-10. PubMed ID: 7193330
    [No Abstract]   [Full Text] [Related]  

  • 20. The role of dopamine in the locomotor stimulant effects and tolerance to these effects of caffeine.
    Powell KR; Iuvone PM; Holtzman SG
    Pharmacol Biochem Behav; 2001; 69(1-2):59-70. PubMed ID: 11420069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.